Skip to main content

and
  1. Article

    Open Access

    The therapeutic potential of RNA Polymerase I transcription inhibitor, CX-5461, in uterine leiomyosarcoma

    Background. Uterine leiomyosarcoma is a rare aggressive smooth muscle cancer with poor survival rates. RNA Polymerase I (Pol I) activity is elevated in many cancers supporting tumour growth and prior studies in ...

    Chang-Won Kang, Katherine M. Hannan, Anneke C. Blackburn in Investigational New Drugs (2022)

  2. Article

    Open Access

    A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction

    Survival rates for pediatric patients suffering from mixed lineage leukemia (MLL)-rearranged leukemia remain below 50% and more targeted, less toxic therapies are urgently needed. A screening method optimized to ...

    Klaartje Somers, Victoria W. Wen, Shiloh M. C. Middlemiss, Brenna Osborne in Oncogene (2019)

  3. No Access

    Article

    RNA polymerase I transcription in confluent cells: Rb downregulates rDNA transcription during confluence-induced cell cycle arrest

    When 3T6 cells are confluent, they withdraw from the cell cycle. Concomitant with cell cycle arrest a significant reduction in RNA polymerase I transcription (80% decrease at 100% confluence) is observed. In t...

    Katherine M Hannan, Brian K Kennedy, Alice H Cavanaugh, Ross D Hannan in Oncogene (2000)

  4. No Access

    Chapter

    Regulation of Ribosomal DNA Transcription During Cardiomyocyte Hypertrophy

    Cardiomyocyte hypertrophy, induced by norepinephrine, endothelin-I, and contraction, is associated with increased rates of protein synthesis and reexpression of genes associated with the fetal gene program. Th...

    Toru Arino, Ross D. Hannan, Kiyofumi Suzuki in The Hypertrophied Heart (2000)